Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
  Breaking News: FDA Approves Triumeq, New Once-Daily Combination Pill
   
Ask the Experts About

Hepatitis and HIV CoinfectionHepatitis and HIV Coinfection
           
Rollover images to visit our other forums!
Recent AnswersAsk a Question
  
  • Email Email
  • Glossary Glossary


Hep C and HIV
May 11, 2001

I have finished the Rebetron treatment for 12 months, When I started my viral load was over a millon copies , at December it was 120,000, at march it was 751.000. I am no longer doing the treatment and, wondering what do I do now?

Please let me know what I should do.

Response from Dr. Rodriguez-Torres

You are a non responder to Rebetron.The majority of patients with HCV in the U.S.are genotype 1, and many did not respond to Rebetron.The next step will be to use Pegilated interferon and Ribavirin.The available data shows that peg-interferon alfa 2-a (Pegasys)and RBV will have the larger number of responders in difficult patients as non responders ,crrhotics and gen.1.You will need to wait a while till the drug is available.



Previous
Test Results
Next
pegasys

  
  • Email Email
  • Glossary Glossary

 Get Email Notifications When This Forum Updates or Subscribe With RSS


 
Advertisement



Q&A TERMS OF USE

This forum is designed for educational purposes only, and experts are not rendering medical, mental health, legal or other professional advice or services. If you have or suspect you may have a medical, mental health, legal or other problem that requires advice, consult your own caregiver, attorney or other qualified professional.

Experts appearing on this page are independent and are solely responsible for editing and fact-checking their material. Neither TheBody.com nor any advertiser is the publisher or speaker of posted visitors' questions or the experts' material.

Review our complete terms of use and copyright notice.

Powered by ExpertViewpoint

Advertisement